Antitumor properties of Coenzyme Q against human ovarian carcinoma cells via induction of ROS-mediated apoptosis and cytoprotective autophagy.

Coenzyme Q (CoQ, 2,3-dimethoxy-5-methyl-1,4-benzoquinone) has been reported to exert anticancer properties against human breast/lung cancer cells. This study investigated the in vitro and in vivo anticancer properties of CoQ on human ovarian carcinoma (SKOV-3) cells and xenografted nude mice, and revealed the underlying molecular mechanism. CoQ induced G/M arrest through downregulation of cyclin B1/A and CDK1/K2 expressions. CoQ-induced autophagy as a survival mechanism was evidenced by increased accumulation of LC3-II, GFP-LC3 puncta, AVOs formation and Beclin-1/Bcl-2 dysregulation. Increased TUNEL-positive cells and Annexin-V/PI stained cells indicated CoQ-induced late apoptosis. Both mitochondrial (caspase-3, PARP and Bax/Bcl-2 dysregulation) and ER stress (caspase-12 and Hsp70) signals are involved in execution of apoptosis. Interestingly, CoQ-induced apoptosis/autophagy is associated with suppression of HER-2/neu and PIK/AKT signalling cascades. CoQ triggered intracellular ROS production, whereas antioxidant N-acetylcysteine prevented CoQ-induced apoptosis, but not autophagy. Inhibition of apoptosis by Z-VAD-FMK suppressed CoQ-induced autophagy (diminished LC3-II/AVOs), indicates CoQ-induced apoptosis led to evoke autophagy. Contrary, inhibition of autophagy by 3-MA/CQ potentiated CoQ-induced apoptosis (increased DNA fragmentation/PARP cleavage). Furthermore, CoQ treatment to SKOV-3 xenografted nude mice reduced tumor incidence and burden. Histopathological analyses confirmed that CoQ modulated xenografted tumor progression by apoptosis induction. Our findings emphasize that CoQ triggered ROS-mediated apoptosis and cytoprotective autophagy.